# Pneumococcal Vaccine Polyvalent

## Pneumovax 23 \(Private\) 0.5mL/dose

| 藥物代碼 | IPNE |
| :--- | :--- |
| 適應症 | Immunization against pneumococcal disease caused by those pneumococcal types included in the vaccine |
| 副作用 | Local inj-site soreness, warmth, erythema & swelling. Fever, headache, malaise, rash, urticaria, arthritis, arthralgia. |
| 禁忌 | Hypersensitivity. Revaccination of adults with Pneumovax 23 is contraindicated except for those at highest risk of pneumococcal infections. Patients with Hodgkin's disease immunised &lt; 7 to 10 days prior to or during immunosuppressive therapy & patients with Hodgkin's disease who have received extensive chemotherapy &/or nodal irradiation. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | To be given IM or SC only. Adult & children &gt;2 years Single dose of 0.5 mL in the deltoid muscle or lateral mid-thigh. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer’s labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

## Pneumovax 23 \(Government\) 0.5mL/dose

| 藥物代碼 | IPNE0 |
| :--- | :--- |
| 適應症 | Immunization against pneumococcal disease caused by those pneumococcal types included in the vaccine |
| 副作用 | Local inj-site soreness, warmth, erythema & swelling. Fever, headache, malaise, rash, urticaria, arthritis, arthralgia. |
| 禁忌 | Hypersensitivity. Revaccination of adults with Pneumovax 23 is contraindicated except for those at highest risk of pneumococcal infections. Patients with Hodgkin's disease immunised &lt; 7 to 10 days prior to or during immunosuppressive therapy & patients with Hodgkin's disease who have received extensive chemotherapy &/or nodal irradiation. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | To be given IM or SC only. Adult & children &gt;2 years Single dose of 0.5 mL in the deltoid muscle or lateral mid-thigh. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer’s labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

## Pneumovax 23 \(Taipei City\) 0.5mL/dose

| 藥物代碼 | IPNE1 |
| :--- | :--- |
| 適應症 | Immunization against pneumococcal disease caused by those pneumococcal types included in the vaccine |
| 副作用 | Local inj-site soreness, warmth, erythema & swelling. Fever, headache, malaise, rash, urticaria, arthritis, arthralgia. |
| 禁忌 | Hypersensitivity. Revaccination of adults with Pneumovax 23 is contraindicated except for those at highest risk of pneumococcal infections. Patients with Hodgkin's disease immunised &lt; 7 to 10 days prior to or during immunosuppressive therapy & patients with Hodgkin's disease who have received extensive chemotherapy &/or nodal irradiation. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | To be given IM or SC only. Adult & children &gt;2 years Single dose of 0.5 mL in the deltoid muscle or lateral mid-thigh. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer’s labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

## Prevenar 13 \(Private\) 0.5mL/dose

| 藥物代碼 | IPR13 |
| :--- | :--- |
| 適應症 | Active immunisation of infants & toddlers against invasive disease caused by Strep pneumoniae serotypes \(4, 6B, 9V, 14, 18C, 19F & 23F\) at 2, 4, 6 & 12-15 months of age. Active immunisation of infants & toddlers &lt; 2 years against otitis media caused by Strep pneumoniae serotypes \(1, 2, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F & 23F\). |
| 副作用 | Decreased appetite, vomiting, diarrhoea, injection site reactions \(e.g. erythema, induration/swelling, pain/tenderness\), tenderness interfering with movement, fever, irritability, drowsiness, restless sleep. |
| 禁忌 | NA |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | Children 24 months-5 years A single dose of 0.5 mL IM, 12-23 months 2 doses of 0.5 mL with an interval of at least 2 months. Infants 7-11 months 2 doses of 0.5 mL with an interval of at least 1 month. A 3rd dose is recommended in the 2nd year of life, 2-6 months 3 doses of 0.5 mL with the 1st dose given at 2 months of age & with an interval of at least 1 month between doses. A 4th dose is recommended in the 2nd year of life. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer’s labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1. 應以肌肉注射方式投予，最好注射在嬰兒大腿前外側的股外側肌，或是幼童上臂的三角肌。 |

## Prevenar \(政府提供13價肺炎\) 0.5mL/dose

| 藥物代碼 | IPRE1 |
| :--- | :--- |
| 適應症 | Active immunisation for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in infants and children from 2 month-5 years. |
| 副作用 | Decreased appetite, irritability, drowsiness/increased sleep, restless sleep/decreased sleep, fever, inj site erythema, induration/swelling or pain/tenderness, rash. |
| 禁忌 | Hypersensitivity. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | 0.5 mL/dose via IM inj. Infant 6 week-6 months Recommended 3-dose schedule: 1st dose at 2 month but can be given as young as 6 week with 1-month interval between doses, followed by a 4th \(booster\) dose to be administered at 12-15 months. Unvaccinated children 2-5 years 1 dose, 12-23 months 2 doses with at least 2-months interval between doses, Infant 7-11 months 2 doses with at least 1 month interval between doses, 3rd dose by 2nd year. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer’s labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1. 應以肌肉注射方式投予，最好注射在嬰兒大腿前外側的股外側肌，或是幼童上臂的三角肌。 |

